Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03396211
Title Study to Evaluate Apatinib Plus Nivolumab in Patients With Unresectable or Metastatic Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors LSK BioPartners Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Sarcoma Oncology Research Center Santa Monica California 90403 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field